Skip to main content
 

HIV PRE-EXPOSURE PROPHYLAXIS (PREP) CLINICAL UPDATES


Date: Aug 25, 2023 09:00 AM - 11:00 AM

CE Hours

2.00

CE Units

0.200

Registration closes on Oct 09, 2023 11:55 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists
PHARMACY TECHNICIANS

Accreditation(s)

Accreditation Council for Pharmacy Education
The Colegio de Farmacéuticos de Puerto Rico is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

HIV PRE-EXPOSURE PROPHYLAXIS (PREP) CLINICAL UPDATES
Registration Closed  

 

At the end of the CPE activity the pharmacists should be able to:

  • Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). 
  • Recognize which patients are potential candidates for PrEP. 
  • Identify recommendations by CDC guidelines regarding PrEP management. 
  • Present an overview of community base PrEP programs or models that have been established in the United States. 
  • Describe the pharmacy team role in PrEP and HIV transmission prevention efforts. 

At the conclusion of the activity, pharmacy technicians should be able to:

  • Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). 
  • Recognize which patients are potential candidates for PrEP. 
  • Present an overview of community base PrEP programs or models that have been established in the United States. 
  • Describe the pharmacy team role in PrEP and HIV transmission prevention efforts. 

Objectives

  • At the end of the CPE activity the pharmacists should be able to: Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
  • Recognize which patients are potential candidates for PrEP.
  • Identify recommendations by CDC guidelines regarding PrEP management.
  • Present an overview of community base PrEP programs or models that have been established in the United States.
  • Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.
  • At the conclusion of the activity, pharmacy technicians should be able to: Describe the difference between HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
  • Recognize which patients are potential candidates for PrEP.
  • Present an overview of community base PrEP programs or models that have been established in the United States.
  • Describe the pharmacy team role in PrEP and HIV transmission prevention efforts.

Speaker(s)/Author(s)

Kalumi Ayala, Pharm.D., AAHIVP, TTS
Clinical Assistant Professor, School of Pharmacy- NOVA Southeastern University

Activity Number

0151-0000-23-025-L02-P/T
Date: 08/25/23
Time: 09:00 AM - 11:00 AM

CE Hours

2.00

Location

Sheraton Hotel & Casino
Registration Closed